Ledger.Open graph →
SEC Form D · filed March 25, 2021

Apnimed, Inc

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Lawrence G. Miller · Cambridge, MAExec · DirectorBarry G. Wohl · Cambridge, MAExecJoseph C. Avellone · Cambridge, MADirectorDennis G. Molnar · Cambridge, MAExec · DirectorGerald G. Chan · Cambridge, MADirectorJames G. Galeota · Cambridge, MADirectorJames Ellis Hammond · San Diego, CAExec · DirectorJeremy Cisneros · San Diego, CADirectorRonald E. Wilhelm · Washington, UTExecFrederic Hervouet · St. Peter's Port, Y7DirectorThomas Chamberlain · St. Peter's Port, Y7Exec · DirectorDaniel Yaghsizian · Boston, MAExec · DirectorRodney M. Hamilton · Franklin, TNDirectorDavid E. Young · Franklin, TNExecAlice L. Deng · San Francisco, CADirectorLeighton D. Read · Menlo Park, CAExec · DirectorJames G. Galeota · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗